PubRank

N A Simonian

Author PubWeight™ 19.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000 4.50
2 Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) Neurology 1998 2.16
3 Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002 1.78
4 Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology 2002 1.61
5 Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996 1.59
6 Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 2001 1.35
7 Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1997 1.14
8 Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology 2001 1.08
9 Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler 2000 1.07
10 Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol 1999 1.00
11 Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol 1995 0.85
12 "Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1999 0.78
13 Effects of nifedipine and nicardipine on regional cerebral blood flow distribution in patients with arterial hypertension. Methods Find Exp Clin Pharmacol 1996 0.78
14 Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997. Neurology 2001 0.76
15 [The influence of an inhibitor and stimulant of nucleic acid synthesis on the development of compensatory hypertrophy and the function of a solitary kidney]. Dokl Akad Nauk SSSR 1965 0.75
16 Comparison of isradipine and enalapril effects on regional carotid circulation in patients with hypertension with unilateral internal carotid artery stenosis. J Cardiovasc Pharmacol 1997 0.75
17 Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration. Eur J Neurol 1999 0.75
18 [Senile changes in organs after a prolonged hyperactivity]. Dokl Akad Nauk SSSR 1965 0.75